Browsing: Oligometastatic

Top Line: What happens if systemic therapy is deferred after SABR for oligometastatic disease?The Study: The SABR-5 study has provided…

It’s hard to keep up with the rapidly unfolding paradigm shifts in the management of oligometastatic non-small cell lung cancer…

Top Line: Does metastasis directed therapy reduce the risk of progression in men receiving intermittent ADT for oligometastatic prostate cancer?The…

Top Line: How do we safely integrate SBRT into targeted therapy or immunotherapy regimens for oligometastatic cancer?The Study: Over the…

As opposed to most available data on recurrent oligomets, this retrospective look at outcomes following radiation to all sites of…

Top Line: Can safe and effective SABR for oligometastatic cancer be translated to a regional cancer network? The Study: The…